Advertisment

Preventing Newborn Hearing Loss: The Role of a Revolutionary Genetic Test

author-image
Mason Walker
New Update
NULL

Preventing Newborn Hearing Loss: The Role of a Revolutionary Genetic Test

Advertisment

In an innovative move to combat the risk of antibiotic-induced hearing loss in newborns, a groundbreaking genetic test has been launched at the Royal Sussex County Hospital in Brighton. The test is specifically designed to identify newborns who may be at risk of hearing loss from the common antibiotic, gentamicin. This antibiotic is the first-choice treatment for neonatal infections as recommended by the National Institute for Health and Care Excellence (NICE). However, it has the potential side effect of causing irreversible hearing loss.

Advertisment

The Role of the Genetic Test

The revolutionary genetic test is conducted through a gentle cheek swab and aims to determine whether a critically ill baby has a single gene change that could cause permanent hearing loss if they are treated with gentamicin. The most significant aspect of this genetic test is that it can swiftly identify this genetic variation, leading to a safer administration of antibiotics.

Dr Jodie Nguyen, a neonatal registrar, stated that the hospital admits around 450 newborn babies each year, many of whom will be unwell and require antibiotics. Therefore, the introduction of this test could prove to be a significant step towards protecting these vulnerable newborns from potential side effects of gentamicin treatment.

Advertisment

Implications for the Family

Dr Cassie Lawn, consultant neonatologist and clinical lead at the trust, highlighted that the results from the genetic test could also provide vital information for the rest of the family. This is because the gene causing susceptibility to hearing loss is maternally inherited. Hence, the information obtained from the test can inform future medical decisions for the mother and maternal siblings.

Importance of Early Identification

Early identification of hearing loss is crucial in minimizing its negative effects on a child’s language, communication, and social skill development. If not addressed promptly, hearing loss can pose significant potential negative impacts on a child’s development and education. Therefore, this innovative genetic testing service represents a monumental step towards systematic, cost-effective, and timely identification and addressal of hearing loss.

In conclusion, the introduction of this innovative genetic test at the Royal Sussex County Hospital is a significant stride towards the safer treatment of newborns against infections. By providing early identification of the potential risk of hearing loss, it not only protects the newborns but also equips the families with crucial information for future medical decisions. While it is a pioneering move in Brighton, it is hoped that this approach will soon be adopted globally to safeguard newborns from potential hearing loss.

Advertisment
Chat with Dr. Medriva !